Analyst firms · Mizuho · SRE
Mizuho SRE price target and rating history
DBA Sempra (SRE) · Utilities
Mizuho rates DBA Sempra (SRE) Neutral with a $84 price target, as of its latest action on Aug 31, 2026. It has published 4 rating actions on SRE since June 2021, including 0 upgrades and 1 downgrade. Across 6 firms with a SRE price target in the last 12 months, the median target is $97.25. Mizuho's $84 is 14% below that.
- Current rating
- Neutral
- Price target
- $84
- Median target, all firms
- $97.25
- Actions on SRE
- 4
Mizuho price target on SRE
Every Mizuho rating on SRE
- Aug 31, 2026
- Dec 22, 2021
- Oct 19, 2021
- Jun 28, 2021
How other firms rate SRE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| HSBC | Buy | $97.50 | Oct 22, 2026 |
| Scotiabank | Sector Perform | $83 | Sep 29, 2026 |
| Jefferies | Buy | $97 | Sep 1, 2026 |
| Mizuho | Neutral | $84 | Aug 31, 2026 |
| TD Cowen | Buy | $110 | Jul 8, 2026 |
| Truist Securities | Buy | $108 | Apr 21, 2026 |
| Argus Research | Buy | Mar 4, 2026 |
Questions about Mizuho and SRE
- What is Mizuho's price target for SRE?
- Mizuho's latest stated price target for DBA Sempra (SRE) is $84, from its action on Aug 31, 2026.
- What is Mizuho's rating on SRE?
- Mizuho rates SRE Neutral, a neutral rating, as of Aug 31, 2026.
- When did Mizuho last change its view on SRE?
- On Aug 31, 2026, Mizuho downgrades to Neutral from Outperform, price target $84.
- How does Mizuho's SRE target compare with other analysts?
- Across 6 firms with a SRE price target in the last 12 months, the median target is $97.25. Mizuho's $84 is 14% below that.
More SRE rating histories
- Jefferies3
- Goldman Sachs5
- Wells Fargo4
- Barclays3
- Morgan Stanley10
- BofA Securities3
- KeyBanc Capital Markets4
All Mizuho ratingsSRE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.